# ELVN ETFs: 53 Funds That Hold Enliven Therapeutics > 53 thematic and core ETFs hold Enliven Therapeutics Inc (ELVN). BOUT holds the most, at 7.26% of the fund on Jul 31, 2026. Data as of Nov 5, 2026. Rebuilt every trading night. ## ETFs that hold Enliven Therapeutics Inc 53 thematic and core ETFs hold Enliven Therapeutics Inc , by holdings dated Jun 30, 2026 to Nov 3, 2026 . BOUT holds the most, at 7.26% of the fund on Jul 31, 2026 . The next largest are CANC (2.55%) and XPH (1.61%). 1 income and other fund on it is listed below. ### Thematic and core funds that hold it | Fund | Name | Share of the fund | Holdings filed | Asset | | --- | --- | --- | --- | --- | | BOUT | CapForce IBD Breakout Opportunities ETF | 7.26% | Jul 31, 2026 | Equity | | CANC | Tema Oncology ETF | 2.55% | Nov 3, 2026 | Equity | | XPH | State Street SPDR S&P Pharmaceuticals ETF | 1.61% | Nov 3, 2026 | Equity | | FMED | Fidelity Disruptive Medicine ETF | 1.35% | Aug 31, 2026 | Equity | | BBC | Virtus Biotech Clinical Trials ETF | 0.80% | Jul 31, 2026 | Equity | | IHE | iShares U.S. Pharmaceuticals ETF | 0.60% | Nov 3, 2026 | Equity | | DWAS | Invesco Dorsey Wright SmallCap Momentum ETF | 0.39% | Nov 3, 2026 | Equity | | FTXH | First Trust Nasdaq Pharmaceuticals ETF | 0.36% | Nov 3, 2026 | Equity | | ACSG | American Century Small Cap Growth Insights ETF | 0.32% | Aug 31, 2026 | Equity | | ESSC | Eventide Small Cap ETF | 0.29% | Jul 31, 2026 | Equity | | IBBQ | Invesco Nasdaq Biotechnology ETF | 0.21% | Nov 3, 2026 | Equity | | TMED | T. Rowe Price Health Care ETF | 0.20% | Jun 30, 2026 | Equity | | FFSM | Fidelity Fundamental Small-Mid Cap ETF | 0.19% | Jul 31, 2026 | Equity | | IBB | iShares Biotechnology ETF | 0.19% | Nov 3, 2026 | Equity | | IWO | iShares Russell 2000 Growth ETF | 0.18% | Nov 3, 2026 | Equity | | VTWG | Vanguard Russell 2000 Growth ETF | 0.17% | Sep 30, 2026 | Equity | | TNXT | T. Rowe Price Innovation Leaders ETF | 0.17% | Jun 30, 2026 | Equity | | AVSC | Avantis U.S. Small Cap Equity ETF | 0.15% | Nov 2, 2026 | Equity | | NUSC | Nuveen ESG Small-Cap ETF | 0.14% | Jul 31, 2026 | Equity | | RFLR | Innovator U.S. Small Cap Managed Floor ETF | 0.13% | Jul 31, 2026 | Equity | | RESM | Columbia Research Enhanced Small Cap ETF | 0.11% | Jun 30, 2026 | Equity | | VFMO | Vanguard U.S. Momentum Factor ETF | 0.11% | Sep 30, 2026 | Equity | | KBFR | Innovator U.S. Small Cap Managed 10 Buffer ETF | 0.10% | Jul 31, 2026 | Equity | | BBSC | JPMorgan BetaBuilders U.S. Small Cap Equity ETF | 0.10% | Nov 3, 2026 | Equity | | IWM | iShares Russell 2000 ETF | 0.09% | Nov 3, 2026 | Equity | | VTWO | Vanguard Russell 2000 ETF | 0.09% | Sep 30, 2026 | Equity | | RSSL | Global X Russell 2000 ETF | 0.07% | Jul 31, 2026 | Equity | | SCHA | Schwab U.S. Small-Cap ETF | 0.07% | Aug 31, 2026 | Equity | | FSEG | Fidelity Enhanced Small Cap Growth ETF | 0.06% | Jun 30, 2026 | Equity | | FESM | Fidelity Enhanced Small Cap Core ETF | 0.06% | Jun 30, 2026 | Equity | | ISCG | iShares Morningstar Small-Cap Growth ETF | 0.06% | Nov 3, 2026 | Equity | | ESML | iShares ESG Aware MSCI USA Small-Cap ETF | 0.05% | Nov 3, 2026 | Equity | | DFAS | U.S. Small Cap Portfolio: ETF Class Shares | 0.05% | Jul 31, 2026 | Equity | | ISCB | | 0.05% | Jul 31, 2026 | Equity | | FHLC | Fidelity MSCI Health Care Index ETF | 0.04% | Jul 31, 2026 | Equity | | VXF | Vanguard Extended Market ETF | 0.04% | Sep 30, 2026 | Equity | | MSML | iShares MSCI USA Small-Cap ETF | 0.03% | Nov 3, 2026 | Equity | | VHT | Vanguard Health Care ETF | 0.03% | Sep 30, 2026 | Equity | | ISCV | iShares Morningstar Small-Cap Value ETF | 0.03% | Nov 3, 2026 | Equity | | WSML | iShares MSCI World Small-Cap ETF | 0.02% | Nov 3, 2026 | Equity | | PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.02% | Nov 3, 2026 | Equity | | MSSM | Morgan Stanley Pathway Small-Mid Cap Equity ETF | 0.01% | Aug 31, 2026 | Equity | | ONEQ | Fidelity Nasdaq Composite Index ETF | 0.01% | Aug 31, 2026 | Equity | | DFAC | U.S. Core Equity 2 Portfolio ETF Class Shares | 0.01% | Jul 31, 2026 | Equity | | GTPE | Goldman Sachs MSCI World Private Equity Return Tracker ETF | 0.01% | Aug 31, 2026 | Equity | | SCHB | Schwab U.S. Broad Market ETF | Enliven Therapeutics Inc (ticker ELVN, listed in US) is matched in every holdings book ETFIQ publishes, by its ticker and name. A share of the fund is the weight its issuer published, as of the Holdings filed date. Shares, preferred shares and debt are told by each fund’s N-PORT asset type. A fund holding only the company’s debt or preferred shares is listed under them, not counted as holding its shares. Options, swaps, futures and cash do not count as holding a company: a call option on a share is not the share. Funds whose book is gross exposure, not a portfolio, are left out. Each row shows the date the fund last filed. Look up another company . ### Questions people ask Which ETFs hold Enliven Therapeutics Inc? 53 thematic and core ETFs hold Enliven Therapeutics Inc, by holdings dated Jun 30, 2026 to Nov 3, 2026. The largest positions are BOUT at 7.26% of the fund on Jul 31, 2026, CANC at 2.55% of the fund on Nov 3, 2026 and XPH at 1.61% of the fund on Nov 3, 2026. 1 income and other fund on it is listed apart. --- Source: ETFIQ, independent ETF data. Recomputed nightly from public filings and prices. Cite: ETFIQ, ETFs holding Enliven Therapeutics Inc, data as of Nov 5, 2026. https://etfiq.com/holdings/elvn/ Licence: https://etfiq.com/license/ Data ETFIQ computes is free to use with attribution: ETFIQ (etfiq.com). Issuer data stays under its owner's terms. HTML: https://etfiq.com/holdings/elvn/